#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vitamin B12 deficiency Still's disease Thromboangiitis obliterans Factor VIII deficiency Henoch-Schonlein purpura Idiopathic pulmonary fibrosis Neuroendocrine carcinoma metastatic Malignant central nervous system neoplasm Arteriovenous malformation Brain injury Neurotrophic keratopathy Cluster headache Marfan's syndrome Anti-myelin-associated glycoprotein associated polyneuropathy Peritoneal mesothelioma malignant More trials…

    Learn about Rare Diseases

    Angiosarcoma – Basic Information Alveolar rhabdomyosarcoma – Treatment Ornithine transcarbamoylase deficiency – Diagnostics Synovial sarcoma recurrent – Treatment Sjogren’s syndrome – Trials in Disease Shprintzen-Goldberg syndrome – Trials in Disease Small intestine leiomyosarcoma – Basic Information Myxofibrosarcoma – Diagnostics Antisynthetase syndrome – Trials in Disease Carcinoid syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbl027.2 Reparixin Olaparib For-6219 Phenylbutyrate Deupirfenidone Jk06 Cisplatin Cefotaxime (-)-PHENSERINE TARTRATE Clobetasol Propionate Human Vaccinia Immunoglobulin Lebrikizumab Ipilimumab Doxorubicin Lbl-007 XENON (133XE) SEVUPARIN Dc-806 Lecanemab More therapies…

    Learn about Your Condition

    Suicidal ideation Alcoholic liver disease Diabetic neuropathy Habitual abortion Agitation Vulvovaginal pruritus Senile dementia Mite allergy Systemic scleroderma Vasospasm Exudative retinopathy Mesothelioma malignant Prader-Willi syndrome Adrenal insufficiency Oesophageal atresia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Aspirin Resistance Testing in Patients 12 to 18 Months After Heart Transplantation Treated with Acetylsalicylic Acid

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart transplant
    Investigated Drugs:
    • Acetylsalicylic Acid
    Austria

  • Skin Prick Test Diagnostic Accuracy Study in Patients with Dermatophagoides pteronyssinus and Dermatophagoides farinae Allergy Using Dermatophagoides pteronyssinus Extract and Dermatophagoides farinae Extract

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Histamine Dihydrochloride
    • Dermatophagoides Farinae Extract
    • Dermatophagoides Pteronyssinus Extract
    Spain

  • Cemsidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    France Italy Poland Spain

  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    • Hormone-dependent prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • BMS-986365
    Germany

  • Progesterone as an Ovulation Trigger in Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Progesterone
    Portugal

  • Atorvastatin, Placebo, and No Treatment in Adults with Familial Hypercholesterolaemia and Statin-Associated Muscle Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Investigated Drugs:
    • Atorvastatin
    Norway
Previous Page
1 … 706 707 708 709 710 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!